Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 3,730.00
+80.00 (2.19%)
At close: Aug 6, 2025, 3:30 PM KST
Accolade Market Cap
Prestige Biologics has a market cap or net worth of 289.63 billion as of August 8, 2025. Its market cap has increased by 10.81% in one year.
Market Cap
289.63B
Enterprise Value
370.40B
Revenue
6.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
$3,730.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 289.63B, a decrease of -52.77%. That is a compound annual growth rate of -15.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 289.63B | -26.50% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 460.93T |
| SK hynix | 177.07T |
| LG Energy Solution | 88.57T |
| Samsung Biologics | 73.24T |
| Hyundai Motor Company | 46.44T |
| Hanwha Aerospace | 45.33T |
| Doosan Enerbility | 42.53T |
| HD Hyundai Heavy Industries | 41.41T |